BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced ...
BOSTON, Oct. 10, 2023 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, and OpSens ...
JMP Securities analyst David Turkaly reiterated a Buy rating on Haemonetics (HAE – Research Report) today and set a price target of $115.00. David Turkaly provided a Buy rating for Haemonetics ...
Haemonetics will shell out up to 185 million euros ($216 million) to acquire Vivasure Medical, a Galway, Ireland-based medtech that makes arterial closure devices.
BOSTON, March 5, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical products and solutions to drive better patient ...
Zacks Investment Research on MSN
Will Haemonetics (HAE) beat estimates again in its next earnings report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...
Haemonetics (HAE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Petusky from Barrington remains neutral on the stock and has a $105.00 ...
Analysts have recently evaluated Haemonetics and provided 12-month price targets. The average target is $87.45, accompanied ...
BOSTON, Jan. 14, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, ...
BOSTON, July 9, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback